Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc. (ticker: PTPI) is an OTC-listed pharmaceutical preparations company. DredgeCap's structured extraction of PTPI's SEC filings surfaces 4 active risk signals, including 2 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. PTPI reported $5.11M in revenue and -$987K for the period ending 2024-12-31, with operating cash flow of -$784K. Cash and equivalents stood at $4.35M (down 51.3% year-over-year). Total assets of $4.39M exceed total liabilities of $2.62M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.